Radioiodine‐Refractory Differentiated Thyroid Cancer: Definition, Molecular Mechanisms, and Advances in Precision Therapy
ABSTRACT Radioiodine‐refractory differentiated thyroid cancer, defined by loss of responsiveness to ¹³¹I therapy or by heterogeneous iodine uptake, accounts for the majority of thyroid cancer‐related deaths; 10‐year survival is approximately 10% with distant metastases. Its definition is not uniform...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2026-08-01
|
| Colecção: | Cancer Innovation |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1002/cai2.70078 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|